LZLiming Zhang

Liming Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liming Zhang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Na Cui

    Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China

    3 shared publications
  • Xiaokai Feng

    Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China

    3 shared publications
  • Chunguo Jiang

    Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Jun Zhang

    Univ Arizona, Dept Med, Tucson, AZ USA

    2 shared publications
  • Song Mi

    Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Ting Wang

    Center for Translational Science, Florida International University, 11350 SW Village Parkway, Port St. Lucie, FL 34987, USA

    2 shared publications

Latest Publications

  • Open Access

    Design and simulation-based evaluation of a novel tracheostomy high-flow therapy device interface: a preclinical study

    by Anna Hou, Song Mi, Fengwei Jiao, Liming Zhang, Zhaohui Tong

    Background: High-flow tracheal oxygen (HFTO) does not generate significant positive end-expiratory pressure (PEEP), which may limit its clinical applicability. We designed a novel high-flow tracheal interface (nHFTI) and compared the PEEP and other respiratory parameters it generated with those of the traditional high-flow tracheal interface (tHFTI) across a range of flow rates. Methods: We conducted a randomized crossover bench study. A size 8 cuffed tracheostomy tube was connected to the high-flow therapy (HFT) device using two different interfaces. A high-fidelity lung simulator was used to model normal lung mechanics. Gas flow rates were set from 10 to 80 L/min at a gradient of 10 L/min, and the sequence was randomized. At each flow setting, the following parameters were recorded: PEEP, peak inspiratory pressure (PIP), peak expiratory pressure (PEP), end-inspiratory transpulmonary pressure (Ptp-EI), end-expiratory transpulmonary pressure (Ptp-EE), end-inspiratory cardiac pressure (PEIC) and end-expiratory cardiac pressure (PEEC), functional residual capacity (FRC), tidal volume (Vt) and fraction of inspired oxygen (FiO 2 ). Results: As the HFT flow rate increased, PEEP increased significantly with both the tHFTI and nHFTI ( P < 0.001). Compared with the tHFTI, the nHFTI generated significantly higher PEEP across most flow rates ( e.g. , 3.4 vs. 1.0 cmH 2 O at 40 L/min; 7.3 vs. 3.1 cmH 2 O at 60 L/min, nHFTI vs. tHFTI, mean values). The nHFTI also generated higher PIP, PEP, Ptp-EI, Ptp-EE, PEIC, and PEEC, and resulted in a greater increase in FRC ( P < 0.010). Compared with the tHFTI, the nHFTI maintained a relatively constant FiO 2 and slightly reduced Vt at the same flow rate level. Conclusions: The nHFTI generated a modest level of PEEP, increased FRC and slightly reduced Vt at flow rates of 40–60 L/min. This physiological profile suggests potential for maintaining lung expansion and improving cardiac function in heart failure. Further in vivo studies are needed to evaluate the clinical impact of nHFTI-mediated PEEP augmentation and determine whether it can lead to improved clinical outcomes, particularly in patients requiring prolonged mechanical ventilation during the weaning process.


  • Open Access

    Serum β2-microglobulin as an independent risk factor for mortality in patients with acute respiratory distress syndrome caused by bacterial infection

    by Na Cui, Xiaokai Feng, Yuntao Zhang, Liming Zhang, Jing Wang

    Acute respiratory distress syndrome (ARDS) is a heterogeneous disease with extremely high mortality. We hypothesized that the serum β2-microglobulin (β2MG) level would be elevated and be an independent risk factor for 28-day mortality in patients with ARDS caused by bacterial infection. We retrospectively enrolled 257 patients with ARDS caused by bacterial infection from January 1, 2015 to February 28, 2021. Patients were followed for up to 28 days and were divided into a survival group and non-survival group according to their clinical outcomes. The serum β2MG levels and other clinical data were collected. The relationship between β2MG levels and 28-day mortality was explored by performing a Cox regression analysis adjusted for age, updated Charlson comorbidity index, disorders of consciousness, septic shock, albumin level, cardiac troponin I level, procalcitonin level, lactic acid level, prothrombin time, partial pressure of arterial oxygen/fraction of inspired oxygen ratio, estimated glomerular filtration rate and Sequential Organ Failure Assessment. In this cohort, 96 patients died in 28 days, yielding a 28-day mortality of 37.4%. The median level of serum β2MG for all enrolled patients was 4.7 (interquartile range [IQR]: 2.9–8.5) mg/L. Higher β2MG levels were significantly associated with 28-day mortality when the β2MG level was analysed as a continuous variable (hazard ratio [HR]: 1.053; 95% confidence interval [CI] 1.004–1.104; P = 0.032) and when it was categorized into tertiles (HR: 3.241; 95% CI 1.180–8.905; P = 0.023). The β2MG level exhibited a high diagnostic accuracy for predicting 28-day mortality (area under the curve [AUC] = 0.732; 95% CI 0.673–0.785; sensitivity: 74.0%; specificity: 64.0%; P < 0.001). The level of serum β2MG is elevated and is an independent risk factor of 28-day mortality in patients with ARDS caused by bacterial infection.


    • 1 January 2023
      • Vol. 15  (8) , 5159-+

    Particulate matter promotes the epithelial to mesenchymal transition in human lung epithelial cells via the ROS pathway

    by Jun Zhang, Xiaoyan Xu, Ying Liang, Xiaomin Wu, Zhongqing Qian, Liming Zhang, Ting Wang

    Objects: Epidemiologic studies have linked exposure to airborne pollutant particulate matter (PM) with increased rates of chronic cardiopulmonary diseases, including asthma and idiopathic pulmonary fibrosis (IPF). Several investigations have suggested that the epithelial-to-mesenchymal transition (EMT) may contribute to the complex pathobiology of environmental exposure-mediated pulmonary fibrosis. The present study was designed to characterize the mechanisms of PM-mediated EMT in human lung epithelial cells (HBECs). Methods and results: PM induced significant dose (0-100 mu g/ml) and time (0-72 h)-dependent increases in transforming growth factor beta (TGF beta) and fibronectin (FN) protein levels in HBECs lysates. PM-activated TGF beta and FN protein production in HBECs was prevented by the antioxidant N-acetyl-cysteine (NAC, 5 mM). Furthermore, the NF-KB inhibitor BAY11-7082 (5 mu M) abolished PM-induced FN production in HBECs. Biomarkers of EMT (ACTA2, SNAIL1 and SNAIL2) in PM-treated HBECs were significantly increased at the mRNA level compared to control cells. Conclusions: These results demonstrate that PM increases protein levels of TGF beta and FN via reactive oxygen species (ROS)-dependent pathways. In addition, PM exposure induces EMT in human lung epithelial cells, supporting a novel mechanism for PM-induced pulmonary fibrosis.


    • 1 January 2023
      • Vol. 15  (8) , 5099-+

    Particulate matter increases connexin 43 expression and exacerbates endothelial barrier disruption

    by Jun Zhang, Xiaomin Wu, Ying Liang, Gabriel Kelly, Janis M. Burt, Liming Zhang, Ting Wang

    Objectives: Particulate Matter (PM) air pollution is known to exacerbate cardiopulmonary diseases. We previously demonstrated that PM mediates endothelial injury and barrier disruption by modulating the endothelial cytoskeleton and cell-cell junctions, but the effects of PM exposure on cell-cell communication and gap junction activity are still unknown. Methods: This study focused on the characterization of PM-regulated endothelial dysfunction through connexin 43 (Cx43), the most abundant gap junction protein expressed in lung endothelial cells (ECs), using cultured human lung endothelial cells and a well-characterized PM sample. Results: PM exposure induced a time-dependent increase of Cx43 in human lung ECs at both the mRNA and protein levels. N-acetylcysteine (NAC), a reactive oxygen species (ROS) scavenger, significantly suppressed PM-induced Cx43 expression. Cx43 proteins on the plasma membrane and ER/Golgi apparatus were elevated in response to a PM challenge. In addition, PM induced gap junction activity, which was indicated by green fluorescence dye transfer between two adjacent ECs. Moreover, GAP27, a selective Cx43 channel inhibitor, attenuated PM-induced human lung EC barrier disruption, which was reflected by rescued trans-endothelial electrical resistance (TER) with an electric cell-substrate impedance sensing system. Moreover, knocking down Cx43 alleviated PM-induced myosin light chain (MLC) phosphorylation. Conclusions: These results strongly suggest that Cx43 plays a key role in PM-mediated endothelial barrier disruption and signal transduction. Cx43 may be a therapeutic target in PM-mediated cardiopulmonary disorders.

  • Open Access

    Analysis of Lymphocyte Profile in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood in Patients With Stage II Sarcoidosis

    by Song Mi, Na Cui, Xiaokai Feng, Chunguo Jiang, Jing Wang, Liming Zhang

    Background: The lymphocyte profile(LP) in mediastinal lymph nodes involved by sarcoidosis has not been extensively studied and the results in the literature were mixed.Methods: This was a prospective study of stage II sarcoidosis patients with intrathoracic lymphadenopathy underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and bronchoalveolar lavage(BAL). LP in lymph node puncture fluid (LNPF),BAL fluid(BALF) and peripheral blood (PB) were evaluated using flow cytometry. The results of LP in PB,BALF and LNPF were compared. The relationship between respiratory symptoms and LP was preliminarily analyzed.Results: In this study, 16 cases of stage II sarcoidosis were diagnosed,11 with respiratory symptoms and 5 without. There was no correlation between LP in LNPF and BALF in all patients. Compared with the proportion of LP in BALF, in LNPF the lymphocytes and B cells increased, the T cells, CD4 , NK T cells and CD4/CD8 ratio decreased, and there was no difference between CD8 T cells and NK cells.Respiratory symptoms had no effect on LP in LNPF. T cells, CD4, CD8 T cells and CD4/CD8 ratio in BALF were correlated with respiratory symptoms, and there was significant difference between symptomatic group and asymptomatic group. Conclusion: The LP in LNPF were significantly different from those in BALF and not correlated with BALF and not with respiratory symptoms, mainly reflect the involvement of lymph nodes, which may be more conducive to the diagnosis and differential diagnosis of sarcoidosis with lymph nodes involved. T cells, CD4 T cells and CD4/CD8 ratio in BALF were positively correlated with respiratory symptoms, while CD8 in BALF and PB was negatively correlated with respiratory symptoms. These indexes may more accurately reflect the pulmonary involvement of sarcoidosis.